Showing 161 - 180 results of 59,704 for search '(( 20 a decrease ) OR ( 5 ((((step decrease) OR (mean decrease))) OR (teer decrease)) ))', query time: 1.05s Refine Results
  1. 161
  2. 162
  3. 163
  4. 164
  5. 165
  6. 166

    Galiellalactone decreases the proportion of ALDH+ prostate cancer cells in vitro and the ALDH1A1 expression in vivo. by Rebecka Hellsten (348459)

    Published 2013
    “…The proportion of ALDH+ cells is expressed as mean ± SEM (n = 2–4). The proportion of ALDH+ DU145 cells were significantly decreased by galiellalactone at the concentrations 10 µM (p = 0.0060), 25 µM (p = 0,0013) and 50 µM galiellalactone (p<0,0001). …”
  7. 167
  8. 168
  9. 169
  10. 170
  11. 171
  12. 172
  13. 173
  14. 174

    The effect of glibenclamide on channel activity at +20, 0 and -20 mV. by Sajjad Salari (736104)

    Published 2015
    “…The addition of 50 μM glibenclamide resulted in a decreased current jump amplitude and a reduction in P<sub>o</sub>. 100 μM glibenclamide caused a total channel inhibition at +20 and 0 mV (n = 5), but was ineffective at -20 mV. …”
  15. 175
  16. 176

    Tunicamycin produces a concentration- and time-dependent decrease in cell viability in SH-SY5Y cells concomitant with caspase-3 activation. by Arindam P. Ghosh (317870)

    Published 2013
    “…<p>(A) Treatment of SH-SY5Y cells with tunicamycin (0.1–5µM) for 24 h caused a progressive decrease in cell viability as measured by Calcein AM cleavage assay. …”
  17. 177
  18. 178

    Table_1_A Strong Decrease in TIMP3 Expression Mediated by the Presence of miR-17 and 20a Enables Extracellular Matrix Remodeling in the NSCLC Lesion Surroundings.DOCX by Karolina H. Czarnecka (8121305)

    Published 2019
    “…<p>Background: Lung cancer is one of the most common causes of death worldwide with a relatively high fatality rate and a mean 5-years survival of about 18%. …”
  19. 179
  20. 180

    The novel <i>carboxylesterase 1</i> variant c.662A>G may decrease the bioactivation of oseltamivir in humans by Jaeseong Oh (3947381)

    Published 2017
    “…A novel <i>CES1</i> c.662A>G single nucleotide polymorphism (SNP) was predicted to decrease CES1 enzymatic activity in an <i>in silico</i> analysis. …”